How parental emotion regulation affects ADHD treatment outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the role of parental emotion regulation in the effectiveness of behavioral parent training interventions for children aged 5-12 with ADHD and oppositional behaviors. It aims to determine if reduced parental emotion regulation and increased emotional reactivity predict poorer outcomes in addressing negative parenting behaviors and children's behavior problems. The intervention consists of an eight-session program focusing on positive reinforcement and structured consequences for negative behaviors. Measurements of parental emotion regulation will be collected through self-reports and objective assessments at various stages of the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Parent of a child ages 5-12 with ADHD
* Parent must report that the child has at least a mild level of symptoms at home of Oppositional Defiant Disorder (ODD) on the Disruptive Behavior Disorder Rating Scale (DBDRS)

Exclusion Criteria:

1. Not being the parent of a child ages 5-12 who meets diagnostic criteria for ADHD.
2. Non English Speaking
3. the child with ADHD has a diagnosis of intellectual delay or has prominent autistic traits
4. Another child in the same family participating in this study already
5. Parent does not have a smartphone or tablet device to complete EMA ratings or does not reside with child for the majority of the time.

Where it's running

• Penn State Health Dept of Psychiatry
  Hershey, Pennsylvania, United States Recruiting

Study contacts

• Study coordinator: James G Waxmonsky, MD
• Email: jwaxmonsky@pennstatehealth.psu.edu
• Phone: 7175318646

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers that predict medication-related side effects in children with ADHD

  This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07900451

• Group CBT vs. Activity Group for Adults with ADHD

  This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.

  Recruiting at 2 sites Region Stockholm · Stockholm and 1 other locations · NCT07834437

• Central Executive Training and Behavioral Parent Training for Young Children with ADHD

  This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.

  Recruiting Florida State University · Tallahassee, Florida · NCT07784348

• Solriamfetol for ADHD in teens: see if it helps with focus

  This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.

  Recruiting at 31 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 30 other locations · NCT07717892

• Solriamfetol for children with ADHD: a 6-week comparison to placebo

  This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.

  Recruiting at 32 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 31 other locations · NCT07717879

• Impact of Sleep Timing and Duration on Teens with ADHD

  This study tests how changing how long and when teens with ADHD sleep affects their attention and daily functioning.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07684417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.